Recent Episodes
Watch recent episodes on
PTV News Review
Scroll Left
Scroll Right
Living Cell Technologies: New Technologies and Clinical Trials




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Living Cell Technologies: New Technologies and Clinical Trials
Released on: January 20, 2010. © PharmaVentures Ltd
Visitors: You are watching a 30 seconds preview.
Get more information and subscribe now
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
  • Summary
  • Transcript
  • Participants
  • Company
In this episode of PharmaTelevision News Review, Fintan Walton talks with Dr Paul Tan, CEO of Living Cell Technologies.

Filmed at AusBiotech 2009, they discuss:

• The company’s origins and aims
• Pig islet transplantation to combat diabetes
• Results of Russian and New Zealand clinical trials
• Living Cell Technologies’ issues with clinical trials in Australia
• The company’s search for a clinical service partner
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Living Cell Technologies's origins and aims
Fintan Walton:
Hello and welcome to PharmaTelevision news review here in Melbourne, Australia. On this show I have Paul Tan, who is CEO of a company called Living Cell Technologies. Welcome to the show.
Paul Tan:
Thank you for having us on your program.
Fintan Walton:
Paul, your company is a company that's involved in the area of diabetes in particular transplantation and the technology you've developed is pig-islets and the transplantation of those pig-islets into humans tell me how the company started and what it's specific aims are?
Paul Tan:
The company started with research that was done by Professor Bob Elliott at the University of Auckland and Bob together with David Collinson a business man started this company because David's son had insulin dependent Type I diabetes, so that research has developed over the years into a new treatment for Type I diabetes the aim of which is to control blood glucose and better control of diabetes overall.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Dr Paul Tan
CEO
Living Cell Technologies

Living Cell Technologies

Living Cell Technologies: Developing cell-based therapies for type 1 diabetes and neurological disorders.

LCT is a New Zealand based biotechnology company focused on developing living cell products for the treatment of diabetes, neurological disease and haemophilia. We have collaborations in Melbourne, Sydney, Auckland, Germany, Italy, Russia and the US.